Search results
vWF deficient plasma, congenital (Type 2B), frozen
For all in-vitro -analyses that require congenital human von Willebrand factor (Type 2B) deficient plasma.
vWF Deficient Plasma, congenital (Type 2A), frozen
For all in-vitro -analyses that require congenital human von Willebrand factor (Type 2A) deficient plasma.
vWF Deficient Plasma, congenital (Type 1), frozen
For all in-vitro -analyses that require congenital human von Willebrand factor (Type 1) deficient plasma.
Factor VIII Inhibitor Plasma congenital, frozen
Human citrated plasma from hemophilia A patients who have developed an inhibitor to FVIII.
BIOPHEN Heparin LRT 5 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra®, Orgaran®, rivaroxaban (Xarelto®), apixaban (Eliquis®) and edoxaban (Lixiana®) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
Factor VIII deficient plasma congenital (frozen)
For all in-vitro -analyses that require congenital human factor VIII deficient plasma.
Factor VIII deficient plasma congenital, pooled (frozen)
For all in-vitro -analyses that require congenital pooled human factor VIII deficient plasma.
LIAPHEN vWF:Ag
Diagnosis of von Willebrand disease. Determination of high vWF antigen levels associated with cardiovascular diseases.
LA Control Plasma High
Positive control for lupus anticoagulant clotting assays.
LA Control Plasma Weak
Positive control for lupus anticoagulant clotting assays.